Literature DB >> 20348948

T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells.

K L Redmond1, N T Crawford, H Farmer, Z C D'Costa, G J O'Brien, N E Buckley, R D Kennedy, P G Johnston, D P Harkin, P B Mullan.   

Abstract

T-box 2 (TBX2) is a transcription factor involved in mammary development and is known to be overexpressed in a subset of aggressive breast cancers. TBX2 has previously been shown to repress growth control genes such as p14(ARF) and p21(WAF1/cip1). In this study we show that TBX2 drives proliferation in breast cancer cells and this is abrogated after TBX2 small interfering RNA (siRNA) knockdown or after the expression of a dominant-negative TBX2 protein. Using microarray analysis we identified a large cohort of novel TBX2-repressed target genes including the breast tumour suppressor NDRG1 (N-myc downregulated gene 1). We show that TBX2 targets NDRG1 through a previously undescribed mechanism involving the recruitment of early growth response 1 (EGR1). We show EGR1 is required for the ability of TBX2 to repress NDRG1 and drive cell proliferation. We show that TBX2 interacts with EGR1 and that TBX2 requires EGR1 to target the NDRG1 proximal promoter. Abrogation of either TBX2 or EGR1 expression is accompanied by the upregulation of cell senescence and apoptotic markers. NDRG1 can recapitulate these effects when transfected into TBX2-expressing cells. Together, these data identify a novel mechanism for TBX2-driven oncogenesis and highlight the importance of NDRG1 as a growth control gene in breast tissue.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20348948     DOI: 10.1038/onc.2010.84

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  37 in total

1.  Clinical significance of serum expression of GROβ in esophageal squamous cell carcinoma.

Authors:  Qiao-Mei Dong; Jin-Qiang Zhang; Qian Li; Jacqueline C Bracher; Denver T Hendricks; Xiao-Hang Zhao
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

2.  TBX2 expression is associated with platinum-sensitivity of ovarian serous carcinoma.

Authors:  Reiko Tasaka; Takeshi Fukuda; Masahiro Shimomura; Yuta Inoue; Takuma Wada; Masaru Kawanishi; Tomoyo Yasui; Toshiyuki Sumi
Journal:  Oncol Lett       Date:  2017-12-29       Impact factor: 2.967

3.  A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition.

Authors:  Sanjeev Kumar; Sun Hee Park; Benjamin Cieply; Jane Schupp; Elizabeth Killiam; Fan Zhang; David L Rimm; Steven M Frisch
Journal:  Mol Cell Biol       Date:  2011-07-11       Impact factor: 4.272

4.  Different effects of long noncoding RNA NDRG1-OT1 fragments on NDRG1 transcription in breast cancer cells under hypoxia.

Authors:  Ching-Ching Yeh; Jun-Liang Luo; Nam Nhut Phan; Yi-Chun Cheng; Lu-Ping Chow; Mong-Hsun Tsai; Eric Y Chuang; Liang-Chuan Lai
Journal:  RNA Biol       Date:  2018-12-04       Impact factor: 4.652

5.  Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis.

Authors:  Dov Hershkovitz; Yonit Gross; Sagi Nahum; Shiran Yehezkel; Ofer Sarig; Jouni Uitto; Eli Sprecher
Journal:  J Invest Dermatol       Date:  2010-12-16       Impact factor: 8.551

6.  The anti-proliferative function of the TGF-β1 signaling pathway involves the repression of the oncogenic TBX2 by its homologue TBX3.

Authors:  Jarod Li; Deeya Ballim; Mercedes Rodriguez; Rutao Cui; Colin R Goding; Huajian Teng; Sharon Prince
Journal:  J Biol Chem       Date:  2014-11-04       Impact factor: 5.157

7.  Clinical significance of serum expression of GROβ in hepatocellular carcinoma.

Authors:  YueGuo Li; YuFang Wang; Peng Zhang
Journal:  Tumour Biol       Date:  2015-03-24

8.  The transcription factors TBX2 and TBX3 interact with human papillomavirus 16 (HPV16) L2 and repress the long control region of HPVs.

Authors:  Marc A Schneider; Konstanze D Scheffer; Timo Bund; Fatima Boukhallouk; Carsten Lambert; Cristina Cotarelo; Gert O Pflugfelder; Luise Florin; Gilles A Spoden
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

9.  TBX2 blocks myogenesis and promotes proliferation in rhabdomyosarcoma cells.

Authors:  Bo Zhu; Meiling Zhang; Stephanie D Byrum; Alan J Tackett; Judith K Davie
Journal:  Int J Cancer       Date:  2014-01-27       Impact factor: 7.396

10.  Genetic analysis of the TBX2 gene promoter in indirect inguinal hernia.

Authors:  Y Zhang; Q Han; H Fan; W Li; Q Xing; B Yan
Journal:  Hernia       Date:  2013-12-06       Impact factor: 4.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.